In gyms and training facilities across the United States and beyond, a once-obscure Southeast Asian tree leaf is quietly moving from fringe curiosity to mainstream talking point. Kratom, derived from the leaves of the Mitragyna speciosa tree, is being woven into some athletes’ routines as they look for new ways to sharpen focus, support recovery, and push through demanding sessions, even as regulators and researchers urge caution about its safety and legal status.
The growing buzz in fitness circles mirrors a wider surge in public interest. Kratom products, which can range from loose powders and capsules to drinks and energy shots, have become more visible online and on store shelves over the past decade. Industry advocates point to user reports of increased energy, reduced discomfort, and improved mood, while federal health agencies emphasize that kratom is not approved as a medication or dietary supplement and may carry significant risks, particularly at higher doses.
Muscle & Fitness spotlighted this trend by highlighting athletes who say kratom helps them enhance the “mind–muscle connection” and stay locked in during training. In that feature, which was labeled as sponsored content, users described taking kratom to manage muscle discomfort, maintain intensity, and tap into what they perceive as smoother, more sustained energy during workouts. The piece also underscored the idea that product quality and consistency are critical concerns for people experimenting with the herb.
Botanically, kratom originates from humid, tropical regions of Southeast Asia, including countries such as Indonesia, Thailand, and Malaysia, where it has a long history of traditional use. The leaves contain dozens of bioactive alkaloids, most notably mitragynine and 7-hydroxymitragynine, which interact with receptors in the brain and body and can produce stimulant-like effects at lower doses and more opioid-like effects at higher doses, according to an overview from the National Institute on Drug Abuse (NIDA).
In fitness settings, kratom’s appeal often centers on its perceived dual character. Some users say that lower amounts deliver a clean, focused lift that makes it easier to tackle long cardio sessions or high-volume strength work, while moderate doses are sometimes described as taking the edge off aches and discomfort after intense training. These observations are largely anecdotal, but they dovetail with laboratory studies that describe how kratom’s principal alkaloids bind to opioid receptors and other molecular targets that modulate pain, mood, and energy, as summarized in a pharmacology review in the open-access journal Frontiers in Pharmacology.
The Muscle & Fitness article also highlighted the role of high-profile athletes in raising kratom’s profile. It noted that some competitors, including two-time Classic Physique Olympia champion Breon Ansley, have publicly associated themselves with kratom brands and emphasized the importance of sourcing products that use “premium and pure extracts.” In a marketplace where supplements are often marketed through athlete endorsements, such testimonials can carry weight among fans and aspiring competitors, even as the article itself cautioned that the magazine was not endorsing any specific brand or product.
Yet the science behind kratom remains a work in progress, and the regulatory environment around it is complex. NIDA notes that kratom can produce both stimulant-like and opioid-like effects, that patterns of use vary widely, and that much is still unknown about its long-term impact on health or its potential therapeutic applications. At the same time, the U.S. Food and Drug Administration has taken a clearly skeptical stance, stressing that kratom is not lawfully marketed as a drug, dietary supplement, or food additive in the United States and warning consumers about risks that include liver toxicity, seizures, and substance use disorder, as outlined on the agency’s dedicated page on FDA and Kratom.
The FDA’s concerns are echoed, in part, in the medical literature. A review of kratom safety and toxicology in the public health context, published in 2024 and available through the U.S. National Library of Medicine, notes that reports of kratom-related exposures to poison centers in the United States have increased alongside rising use. The authors describe a spectrum of reported adverse events, ranging from nausea and constipation to more serious issues such as respiratory depression and, in rare cases, death, often in situations where kratom was used in combination with other substances, as detailed in the article “Kratom safety and toxicology in the public health context” on the National Institutes of Health (NIH) database.
For the fitness community, the practical implications of this tension between user enthusiasm and regulatory caution are significant. On one hand, some athletes are attracted to kratom as a plant-based alternative to conventional pre-workout formulas, painkillers, or sleep aids, particularly those wary of long-term reliance on prescription opioids. On the other hand, federal agencies underscore that kratom’s pharmacology overlaps with that of opioids, and that dependence, withdrawal symptoms, and toxicity are documented possibilities, as outlined in a clinical overview on StatPearls (NCBI Bookshelf).
Legal status adds another layer of complexity. In the United States, kratom occupies a patchwork landscape: it is accessible in many states but restricted or banned in others, and at the federal level it remains unapproved for medical use or as a dietary supplement. NIDA notes that kratom and kratom-based products are currently legal and available in many areas, but this access is unfolding amid ongoing debates among policymakers, researchers, and consumer advocates about how best to regulate the substance and protect public health.
Within this evolving context, brands featured in fitness-oriented media, such as the Your Kratom products referenced in Muscle & Fitness, are positioning their offerings as tools for performance and physique enhancement. Marketing typically emphasizes user testimonials about improved focus, better tolerance for demanding workouts, and quicker perceived recovery. At the same time, athletes and consumers are left to navigate a largely unregulated marketplace where product potency, purity, and labeling accuracy can vary, which is one reason health authorities repeatedly urge people to approach kratom with caution.
Another key issue is that the evidence base about kratom’s role—if any—in sports performance is still thin. Most of the available research has concentrated on how kratom is used for self-managed pain relief, mood modification, or as a potential aid in reducing opioid use, rather than as an ergogenic aid for exercise. NIDA has outlined its ongoing efforts to examine kratom’s mechanisms, potential therapeutic uses, and health impacts, underscoring that “much is still unknown” and that current understanding is insufficient to support its use as a medical treatment or performance supplement.
For strength and physique athletes, the stories circulating around kratom often focus on the subjective experience of connecting more deeply with each repetition or pushing through what would otherwise be workout-ending fatigue. Some users describe a sensation of being “locked in” mentally while their perception of discomfort is blunted, a combination they believe helps them execute training plans more faithfully. Those same qualities, however, are precisely what worry critics who argue that masking pain or fatigue can encourage people to ignore early warning signs of overuse, injury, or underlying health problems.
Public health experts also flag the risk of contamination or adulteration in some kratom products. Because kratom is not approved as a dietary supplement or food additive, it does not go through the same premarket evaluation process that the FDA requires for such products, and some past enforcement actions have focused on kratom items that contained high concentrations of particular alkaloids or were marketed with unproven medical claims. Consumer-oriented outlets have documented cases in which people experienced serious side effects after using kratom, prompting warnings about unsupervised use and unverified products, as explored in coverage such as Consumer Reports’ explainer “What You Should Know About Kratom” on ConsumerReports.org.
For now, experts generally recommend that anyone considering kratom—whether for fitness, pain relief, or other reasons—discuss it with a healthcare professional, particularly if they have underlying medical conditions, take other medications, or have a history of substance use disorder. Physicians and pharmacists can help identify possible interactions and assess individual risk, drawing on emerging clinical data and guidance from agencies like the FDA and NIH, even as both acknowledge that the evidence is still developing.
As research expands, scientists are probing whether kratom-derived compounds might one day have more precisely defined roles in medicine. NIDA supports preclinical work to explore how kratom’s alkaloids behave in the brain, whether they might be modified for safer therapeutic applications, and how they compare to existing pain and addiction treatments. That work, which is still at an early stage, underscores an important nuance: the fact that a plant contains potentially useful molecules does not mean that crude or unregulated preparations are safe or effective for general use, especially in demanding environments like high-level sport.
In the meantime, kratom’s place in the fitness world remains unsettled. Articles like the Muscle & Fitness feature have helped introduce the herb to a broader audience of athletes, while ongoing warnings from federal regulators and cautious assessments in the medical literature highlight the distance between anecdote and evidence. For lifters, runners, and competitors deciding whether to experiment with kratom, the current landscape is one of competing narratives: on one side, enthusiastic reports of focus, energy, and relief; on the other, sober reminders that this is a psychoactive substance with opioid-like properties, uncertain long-term effects, and a regulatory status that is still very much in flux.
How that tension resolves will depend on the trajectory of future research, the evolution of national and state policies, and the willingness of consumers to look beyond marketing claims to the underlying data. Until then, kratom’s rise in the fitness community serves as a reminder that even as athletes search for every possible edge, the most powerful tools for performance and longevity remain the fundamentals: smart training, adequate recovery, and open dialogue with qualified health professionals about any substance—herbal or otherwise—that promises to accelerate results.